Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arrowhead Pharmaceuticals Q1 Results Didn't Matter -- but Its Pipeline Update Did

TheMotleyFool

0 0

Arrowhead Pharmaceuticals Q1 Results Didn't Matter -- but Its Pipeline Update Did

Arrowhead Pharmaceuticals (NASDAQ: ARWR) ranked as one of the biggest biotech winners in 2019, racking up a gain of 410%. The stock has given up some of those gains in 2020 so far, though.

But a rebound could now be on the way. Arrowhead announced its fiscal 2020 first-quarter results after the market closed on Wednesday. Here are the highlights from the company's Q1 update.

Image source: Getty Images.

Source Fool.com

Like: 0

ARWR

Share